4//SEC Filing
Grunberg Gregory 4
Accession 0001179110-18-012105
CIK 0001479419other
Filed
Oct 8, 8:00 PM ET
Accepted
Oct 9, 4:46 PM ET
Size
5.0 KB
Accession
0001179110-18-012105
Insider Transaction Report
Form 4
Grunberg Gregory
Director10% Owner
Transactions
- Purchase
Common Stock
2018-10-05$8.25/sh+606,060$4,999,995→ 2,877,006 total(indirect: By Longitude Venture Partners II, L.P.)
Footnotes (1)
- [F1]These shares are held by Longitude Venture Partners II, L.P. The Reporting Person is a member of Longitude Capital Partners II, LLC, the general partner of Longitude Venture Partners II, L.P., and may be deemed to share voting and investment power over these shares. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Documents
Issuer
Kala Pharmaceuticals, Inc.
CIK 0001479419
Entity typeother
Related Parties
1- filerCIK 0001711080
Filing Metadata
- Form type
- 4
- Filed
- Oct 8, 8:00 PM ET
- Accepted
- Oct 9, 4:46 PM ET
- Size
- 5.0 KB